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The anchoring filaInent cOInponent laIninin 5 (kali-
nin/nicein) is a candidate protein for Inutations in 
SOIne hereditary blistering skin disorders. In this 
study, laIninin 5 expression was assessed in a faInily 
with generalizea atrophic benign epiderInolysis bul-
losa, a non-lethal variant of the junctioQ.al forIn of 
epiderInolysis bullosa. IInInunofluorescence Inicros-
copy of the skin baseInent-IneInbrane zone with a 
Inonoclonal antibody (GB3) revealed reduced an ti-
laIninin 5 staining cOInpared to norInal controls. The 
labeling, when exaInined by iInInunoelectron Ini-
croscopy, was present within the lower laInina lucida, 
iInInediately below the plane of blister forInation. 
NUInerous heInidesInosoInes and well-forIned an-
choring filaInents were seen on transInission electron 
Inicroscopy. PolYInerase chain reaction aInplification 
of genoInic DNA encoding the /33 subunit (LAMB3) of 
T he mechanobullous disorder, junCtiona.l epidermoly-sis bullosa (TEB), is a heterogeneous condition with descriptions of both ledlal and non-lethal variants [1-3] . Generalized atrophic benign epidennolysis bullosa (GABEE) is a rare fonn of non-lethal ]E B and was first 
reported using tlus nomenclature by Hintner and Wolff [4]. Apart 
from skin fragility, it is associated with widespread atrophic skin 
changes, alopecia, reduced aA.-illary and pubic hair, dysplastic teedl, and 
dystropluc nails. Several additional cases of GABEE widl similar 
clinical features, and with ultrastructural evidence of blistering widun 
the lamina lucida and variable changes in henlidesmosome and an-
choring filament l110lphoiogy, have been reported [5-9]. 
Recently, evidence has em erged invoking the t1u-ee genes thin 
encode the anchoring filam ent protein laminiJl 5 as candidate genes 
Manuscript received November 2, 1994; revised December 16, 1994; 
accepted for publication January 24, 1995. 
This work was presented at the 24th Al1l111a.l Meeting of the European 
Society for Dermatologica l Research on 27 September 1994 in Vienna, 
Austria. 
R eprint requests to: Dr. J o uni Uitto, Department of Dermatology, 
J efFerson Medical College, 233 South 10th Street, Room 450 BLSJ3, 
Philadelphia, PA J 91 07-554l. 
Abbreviations: ASO, aUele-specific o ligonucleotide hybridization ; 
GABEB , generalized atrophic benign epidermolysis bullos,,; PTC, prema-
ture te rmina tion codon . 
laIninin 5, heteroduplex analysis of the polYInerase 
chain reaction products, and nucleotide sequencing 
of the heteroduplexes revealed two putative Inuta-
tions within the LAMB3 gene; these consisted of a 
preInature terInination codon in exon 3 and a Inis-
sense Inutation in exon 7. Exons 3 and 7 encode part 
of dOInain VI of the laIninin 5 /33 chain short arIn. 
This globular dOInain of the protein has been postu-
lated to have an iInportant function in the interaction 
of laIninin 5 with other structural cOInponents of the 
baseInent IneInbrane zone, such as laIninin 6 (K-
laIninin). Thus the Inutations delineated in this faIn-
ily Inay have a critical pathogenetic significance in 
reducing adhesion between the epiderInis and the 
derInis. Key words: jlltl.ctioltal epiderlllolysis bllUosalkali-
ttitr./uicein. ] [ttvest Del"tllatol 104:467-474. 1995 
for ] EB. In particular, immunofluorescence studies using antibodies 
to laminin 5 have shown reduced or absent skin basement mem-
brane zone labeling in JEB [10-1 2]. Lami.nin 5 consists of three 
sublmit polypeptide chains, 0:3, {33, and y2, encoded by distin ct 
genes LAMA3, LAMB3, and LAMC2, respectively [13] . T h ese 
polypeptide chains (formerly known as nicein / kaluun A, B 1, and 
B2 chains) foml a heterotrinleric m o lecule, ruld all du-ee are required 
in d1e assembly of functional lrunUun 5 macromolecules. Specific 
mutations in both d1e LAMB3 and LAMC2 genes have been reported 
in patients with either letlla.1 or non-ledlal JEB phenotypes [14-16]. 
In tlus study, we have searched for mutations in lamulin 5 in a 
family containing t1u-ee affected members with GABEB. Skin 
samples were assessed by electron microscopy and by immunoflu-
orescence and pre- embedding imm unogold electron nucroscopy, 
using the GB3 m onoclonal antibody (rulti-laminul 5) [10] . Poly-
m erase chain reaction (PCR) amplification of genomic DNA 
segments and heteroduplex analysis was used to screen for mu ta-
tions, fo llowed by nucleotide sequencing of any observed hetero-
duplex. Sequence abnormalities were then confim1ed by restriction 
endonuclease digestion or allele-specific oligon ucleotide (ASO) 
hybridization . Transcdpt levels for LAMB3 were also assessed from 
cul tured keratinocytes derived from two affected patients. Reverse 
tramcription (RT) PCR followed by hybridization with oligonu-
cleotide probes to the relevant exon borders was perfonned to 
assess cDNA structure. 
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MATERIALS AN D M ETHODS 
P a tient D a ta Complete clinica l exam ination of the affected members of 
the f.1m il y was carri ed out by at least two of the authors. Two 6-mm punch 
biopsies of skin were ta ken under local anesthesia from the uppcr arm in all 
the affected fam ily Il1 cmbers. Non- Iesional skin that had bcen rubbed gently 
with an eraser for 5-1 0 scconds was sampled. O ne biopsy specimen was 
d ividcd fo r im munofluorcsccnce, e lectron microscopy, and immunoelec-
tron11licroscopy studies. T he o ther was used to ini ti ate keratinocyte culture. 
C ul turing was pe rfo rmed by a feede r laye r method as described previo usly 
11 7J. 
Immunofluorescence Immunoflu orescence studies were pcrformed on 
5-/.un cryostat sections, as reported previously [I B] . Primary antibodies 
consisted of GB3 (kindly provided by Profcssor J - P. O rtonne, Hopi ta l 
Pasteur, N icc), LH7:2, and type IV co llagen antisera (IC N 111lmunobio logi-
cals, UK) . GB3 anti body labels components of laminin 5 w ithin the lamina 
lucida [19,20] and has been shown to havc attenuated or completcly absent 
staining in j unctiona l forms of EB. LI-I 7:2 antibody rccognizes an epi tope 
within the NC-l domain of type V II co ll agen [21] ; labeling w ith thi s 
antibody has been shown to be variably reduced or abscnt in diffe rent 
subtypes of the dystro phic fo m1 ofEB [22] . Type IV co llagen is a ubiqu itous 
component of the lamina densa [23] . T I1ese al1tibodies were di lu ted 1 :2, 
1 :50, and 1:100, respectively, in phosphate-bufI'cred sa linc/bovine se rum 
albumin . Labeling was visualized using fluorescein-conjugatcd rabbit an ti-
mouse and goat anti-rabbi t IgG antibodics (IC N Imll1unobio logica ls, U K) 
diluted 1 :50 in phosphate-buffered sa linc/bovin e se rum albumin . 
Ele c tron Mic ro scopy Skin samples werc processcd for elcctron micros-
copy using standard methods [24] , with primary fixatio n in half-s trcngth 
Kamovsky fixativc (containing 2% fo rm aldehyde and 2.5% gluta raldehyde 
in 0.04 M cacodylate buffer), and secondary fixation in 1.3°;', osmium 
tetroxide in d isti ll ed water. 
Imnl uilociectro n Mic roscopy Skin samples from the affected f.1m il y 
members and three contro l " lmples fro m normal sk in in unrelated, unaf-
fected indi viduals werc processed fo r immunoelcc tron microscopy, using a 
prc-embedding method. Flil l detail s of thi s tcchnique, includ ing labeling 
with thc GB3 antibody, have been reported elsewhere [25]. 
PCR Antplification a nd Heteroduplex Ana lysis DN A was iso lated 
from peripheral blood lymp hocytes by standard mcthods [26J and used as a 
template for amplification of genomic sequences w ithin LAMB3. O ligonu-
cleotide primcrs spann ing each of the genc's 23 cxonS werc synthesized on 
the basis ofintronic seq uences to gencrate PCR products 127 1. Specifica lly, 
to am pl ifY exons 3 and 7 (sec resul ts) the fo llowing pri mers wcrc used . For 
exon 3, the upstream primer was 5' AATTATTACTGCCAGCAGCG 3' 
and the downstream primer was 5' TACATTTCCTCTTGCCCAA 3' . 
For exon 7, the upstream primer was 5' AGGTTTCTTCTGAACTCGGG 
3' and the downstream primer was 5' GCAGGGCAAGTATCAAATCC 3' . 
For PCR ampHficatiun, approximately 250 IIg of genomic D NA was used as 
the tcmplate in an amplification buffcr con t<1 ining 20 pn;o l of cach primer, 
100 nmol MgCI2, 20 JLmol of each nucleotidc , and 2.5 U ofTaq Polymerase 
(Gibco BR.L, Gaithersburg, MD) in a tota l vo lumc of 50 ,.d . T he am plifi-
cation conditions for both sets of pri mers were 94°C fo r 5 min; then 94 °c 
fo r 45 seconds; 56°C for 45 seconds; 72°C fo r 45 seconds, fo r 40 cycles in 
an OmniGene then na l cycler (Marsh Scicntiflc Inc). Aliquots of 5 ILl of thc 
pCR products wcre analyzed on 1 % agarosc gel electrophoresis and 10 JLI 
of the sample was prepared fo r heteroduplex analysis as per the man uf.,c-
tu rer's recommen dations (MOE, JT Baker Inc, Phill ipsburg, NJ ). Sta ining 
with ctllid iu m brom ide was used to visuali ze the heterodup lexes. If a 
heterodu plex was detected, the PCR. product was subcloncd into thc pT7 
vector (Novagcn, Mad ison, W I, USA) and sequenced by standard did eo,,""Y 
nucleotidc teclU1iques [2B]. 
V e rificat io n o f the Mutations T he mutations detected in the PC R 
products (sec Reslilts) were verified in genomic D N A. T he exon 3 mutation 
resu lted in the creation of a new restriction sitc fo r the endonucleasc Odc I. 
Thc PCR products spanning tlus cxon were cleaved with tlus enzymc 
accord ing to thc manufacturers instructions (Ncw England Bio labs). To 
verifY the exon 7 mutation , o ligonucleotide probes covering the site of 
the mutation were des igncd fo r ASO of the P R prod ucts encompassing 
exon 7. A standard ASO protocol was used [29 J. T he probcs werc, fo r the 
wild type, 5' AAAAATTCAAGGTCAGTGTGG 3' and fo r the mu tated 
allelc, 5' AAAAAATTCAAAGTCAGTGTGG 3'. Sevcnty-five cthnica ll y 
matchcd, unrelated hea lthy rontro ls were also assessed fo r thc presence or 
abscnce of this m utation . 
RNA Isola tion a nd Northern Analysis Total ltN A was isolated by the 
guanidiul11 isothiocyanate extrac tion method 130] from cultured kcr;ltino-
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cytes from two affected individuals and One unrelated non-affected contro l . 
Approximately 20 ILg of total RN A from cach sample was e lec trophoresed 
on a 1 % dcnaturin g ge l conta ining 1.2 M fo rma ldehyde. T he RNA was the" 
transferred onto Zeta-Probc blotting membra ne (B io-Rad , Melville, NY). 
T he membrane was hybridized w ith a 32 P_labeled eD NA probe fo r the {33 
chain of LA MB3 [31], as wcll as wi th labeled cD N A speci fi c for huma" 
glyce raldehyde-3-phosphate dehydrogenase (GA PDH) [32] . T he labeled 
mcmbranes were then exposed to X-ray fi lm (Hypcrfi lm Mp, Amcrsham , 
Arlington Heights, rL) at - 70°C and devcloped aftcr 1B- 24 h o f ex posure . 
T he re lative m.R.NA levels w cre determined using an ultrascan X L laser 
densito meter (LKB Bromma). 
R T -PCR Because the cxon 7 mutation (see R eslllt .• ) occurrcd wi thin the 
splicc site consensus scquence at the 3' end of cxon 7 and m ight thercfore 
havc an effec t on splicing of the in trons, o ligonucleotide probes were 
des igncd to spa n the exon borders of t11C adj acent exons in the affectcd 
individuals' cD N A, whjch was synthesized with reversc transcriptase using 
approximate ly 50 JLg o f tota l R.N A in a volunle of 100 ILl acco rdiJ1g to the 
manu f;lcturer's recommendations (Bcthesda R esearch Labo ratories, Ga ith_ 
ersburg, MD). T he o ligonucleotide probes synthes ized wcre as fo ll ows: fo r 
ex on 6-exon 7 junction, S' TGGGGGGAAGGTCCA ACTTA 3'; for exol') 
6-cxon Bjunction, 5' GGGGGGAAGAGGTGGGGG 3'; fo r cxon 7-exon 8 
junctio n, w ild type,S' AAATTCA A.G.AGGTGGGGGAG 3'; and fo r cxon 
7-cxon B, wi th mutation , S' AAATTCAAA AGGTGGGGGAG A 3'. Dot 
blotting '111 d probe hybrid iza tion were then perfo rmed as described else_ 
whcre 129]. 
RES U LTS 
Clinical a nd Genetic F eatures of the F amily AJ I three 
affected fa m il y m embers, in the ir 30s w h e n examin e d , had a hi sto ry 
o f gen c ra li zed t rauma-induced bli ste r in g fro m binh , w hic h p a rtic-
u larl y affec te d th e lo w e r legs . In additio n to th e clinica l features 
sh o wn in F ig 1 , sp arse sccondm'y sexu al ha ir , patc h y a tro phic: 
a lo pecia, and a lbostr ia te les io n s o n the tru n k w e re a lso p resent . 
Furth e r cli n ica l d eta ils o f th is fam ily h a ve bee n descr ibe d e lsew h e re 
[3 3] . T h e fa mily contains three affected and th ree unaffected 
ofEprin g; both p are n ts ha ve n o skin abn o rma lities . T h e pa ttern of 
inherita nce is con sisten t w ith an a u tosom a l recess ive gen o d e rm a_ 
tosis (see F igs 5 and 6) . 
Laminin 5 L abeling Is Reduced at the Dermal-Epidermal 
Junction In th e a ffecte d indi v idua ls, G B 3 an t ibo d y labe li n g 
showed f:Jint, ye t cl earl y d e tecta b le, lin ear d erma l-ep id e rma l j unc_ 
tio n flu o rescent stai n in g w h e n compa re d to t h e brig h t , conti nu o u s 
linea r lab e l in g in t h e n o rma l con tro l skin (Fig 2A,B) . Typ e IV 
coll agen antisera labe li n g w as present a lo n g t h e d e nllaJ- epide nmtJ 
junc ti o n and surro un d ing d e rma l b lood vessels an d n e rves. In a re a s 
of b listerin g, anti-typ e LV collagen stainiJl g w as present a lo n g th e 
b lister ba se (Fig 2C), co n siste n t w ith b li ster fo rmat ion occurrin g 
a b o ve th e lamina d e n sa . Sta inin g w ith LH7 :2 antibo d y (anti-type 
VII collagen) g ave b ri g h t lin ea r sta in in g a t th e d e rm al- e pide rmal 
junc ti o n in a ll cases, of simi lar in ten sity to n o rmal con tro l skin (not 
sh own) . In a reas o f b lister fo rmatio n this a n t ib o d y labe le d t h e 
b liste r base . 
Ultrastr uctural Preservation of Helnidesmoson~es and An_ 
choring Filalnents O n th1l1 smiss io n e lectr o n m icroscop y, lo w _ 
mag nifi ca t io n exam ina tio n re ve a le d num e ro u s are a s of e p id e rm al-
d e rm a l d etac h m e n t w ith th e plnn e o f cl e ava ge occu rrin g with in th e 
lamina lu cida (F ig 3A) . Hig h e r mag nifi cation o f the h e mides l11 O_ 
som e-an c h o r in g fi lam e nt complex sh o w e d 110 g ross st ructura l 
a bno rmali ties (F ig 3B,C) . M ost he m id es l11osom es h ad w e ll-de fi n e d 
inne r a nd o u te l' plaqu es. S ub- ba sa l d e nse p lates w e re o ften presen t, 
and num e rous fin e a n c h o ri n g ti lam e n ts cou ld b e seen extending 
across th e lam in a lu c ida fro ni t h e b asal k e ra tinocyte plasm a m e m_ 
bra n e to t h e lamina d e n sa (Fig 3C). Exami.na t io t1 of th e roof o f <I 
bliste r sh owed , in som e in stances, h e midesm osom es w ith subja cen.t 
·sub- b asal d e n se p la tes . and wisp y an c h o r in g ti lam c n ts exte n d in g 
in to the b li ste r cavity (F ig 3D). 
Laminin 5 Immunolabeling Is L ocalized to the Lower Lam_ 
ina L ucida Subjacent t o Hemideslnosomes U lt rastl'u c tur_ 
a ll y, G B 3 imm u l10lab e ling in n o rma l h u man skin w as presc "~t 
wi thin th e lo w e r lamin a lu c id 'l just abo ve th e la min a d e n sa (Fig 
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Figure 1. Clinical appearances of the affected faluily l11elIlbers . A) A sero-sangllinous blister on the lower abdomen with surrounding erythema and 
crusting. B) Ma rked involvement of the lower limbs with slow-healing erosions, prominent erythema and sOllle atrophy. C) Extensive blistering, scaling, 
atrophy, erythema, and crusted scro-pustular exudate formation on the lower limb. D) Dorsal aspect of the foot showing an inflammatory pustular blister 
and crusted eros ions with almost complete loss of the nail plates from all the toes . E) A finger nail showing dystrophic changes with scarring and only a small 
amount of residua l nail p late. F) Coalescing pigmented plaques on the inner thigh w ith scattered blisters and scaling. G) Abnormal dentition with extensive 
enamel hypoplasia, focal pitting, and consider;lble disco loration of all the teeth. H) Marked loss of eyelashes with mild scarring of the lower blepharal margin. 
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Figur e 2. Indirect immunofluorescence microscopy shows that GB3 antibody labeling at the dermal-epidermaljunction is reduced. A ) GB3 
an tibody stain in g in noml al control skin . T here is bright , linear staining at the derma l-epidermal junction. B) GB3 antibody staining in pati ent skin . R educed 
intensity fluorescen t labeling is present at the demlal-epidermal jUJlction . C) Anti-type IV collagen antibody staining in patien t skin. Labeling is present at 
the dermal-epidermal j unction , including along the base of a blister, w hereas the roof (m1"O IIIs) is unJabelcd . (Bar, 50 p.m.) 
4A ). T he labeling was ·m aximal subj acen t to hemidesm osom es and 
was seen in association with the anchoring filam ents (Fig 4B) . In 
intact patient skin, a redu ced am ount of sinlilarly distributed 
im m unolabeling was seen (Fig 4q, although notably not all 
anchoring fila m ents showed GB3 labeling. In areas of separation, 
som e scattered GB3 immunolabeling was de tected on the upper 
border of th e lamina densa in the blister base with no associated 
anchorin g filaments (Fig 4D). In some areas of patient skin, focal 
aggregates of immunogold anti-GB3 immunolabeling w ere present. 
In such sites, no adj acent normal pattern of immunolabeling w as 
detected (Fig 4E). 
I d e ntifica tion of the Mutations Within LAMB3 H eterodu-
plex analysis of the PC R products spannin g the 23 exons ofLAME3 
in the probands' DNA revealed five distinct shifts. Two of these 
allelic variants were considered to be pathogenetic in a compound 
heterozygote (Fi g s SA a nd 6A ) . Firstly , nucleotide sequencing o f 
the exon 3 heteroduplex o riginating from the m aternal alle le 
showed the presence of a C-to-T transition at nucleo tide position 
123 (Fi g SB). T his poin t mu ta tion changes an arginine residue 
(CGA) into a premature termin ation codon (T GA) . Secondly, 
nucleotide sequencing of the exon 7 h eteroduplex from the 
paternal aUele showed a point mutation , with a G-to-A transition at 
n ucleotide position 628 (Fig 6B) . T his change occurs within the 
las t nucl eotide of exon 7 and causes a missense mutation, substi-
tuting lysine (AAG) for glutamic acid (GAG) . 
Two additional nucleotide substitu tions that did not chan ge th e 
amino acid sequence were detected in exon 6 (384T - to-C, CCI to 
CCC, proline) and in exon 23 (3432A- to-G, TCA to TCG, serine) . 
T h ese si lent polymorphism s have been noted in several o ther 
unrelated patients and normal control subjects [34]. Sequencing of 
the fifth heteroduplex revealed a nucleotide dele ti on (2702-
12de1G) w ithin intron 18 bu t occurriJlg 12 bp away from the 
consensus splice j unction , and the refore unlikely to influ ence RNA 
processiJlg. 
Verification of the Mutations Within LAMB3 T he C-to-T 
transition in exon 3 was verified by restriction endonucl ease 
digestion using the enzym e D de I (New England Biolabs, Beverl y, 
MA), which creates a new restriction site (CIGAG) in the mutated 
allele (Fig sq. In the wild type allele, digestion with this enzyme 
divided the PCR p roduct iJlto fragments 246, 11 0, and 69 bp in 
size . In the mutated allele, the 246 - bp fragment w as furthe r 
cleaved iJlto 227- and 19-bp fra gm ents. Thus, in the individual s 
heterozygous for tills mutation , i.e ., the m other and the three 
individuals with GABEB, two distinct bands (246 and 227 bp) could 
readily be appreciated (Fig sq. 
T he exon 7 mutation did not create or abolish a restriction 
endonuclease digestion site and w as therefore verified by ASO (Fig 
6q. Only the mother and one unaffected offspriJlg were homozy-
gous fo r the wild-type all ele , whereas the remaiJlde r of the f3lilily 
w ere noted to have bo th the wild-type and the mutated allele. 
However , only the three affected individuals had bo th the exon 3 
and exon 7 mutations, thus be iJlg compo und he terozygotes. 
R T -PCR of cDNA derived from cultured keratinocytes fi:om 
two affected fanilly m embers did not demo nstrate any abnorm al 
splicing of exon 7, despi te the point mutation occurring witllln the 
splice site consensus sequence. Specifically, ASO across the exon 
6 - exon 8 border (i .e. , fo r skipping o f ex on 7) w as negative , 
whereas the normal exon 6-exon 7 borders and exon 7-exon 8 
borders were detected. In addition, the missense mutation w as 
noted in the patients' cDNA USiJlg the ASO approach. 
Northern analysis fo r the LAMB3 gen e (Fig 7). in the affected 
patients revealed mR.NA levels that w ere reduced to approxinlately 
3 5% of that in an unrelated, un affected control subject. 
DISCU SSION 
T here are three main types o f epidennolys is bullosa , nam ely, the 
simplex, junctional, and dystropillc. R ecently, substantial advan ces 
have been m ade in understanding the molecular basis of each 
category ofEB. Specifi ca Uy, mut,ltions wi thin the genes fo r ke ratin 
5 and 14 have been reported iJl EB simp lex, and iJl the type VlI 
collagen gene (C O L7A1) in dys trophic EB [3 5- 38] . In junctional 
EB , the pathogenetic changes appear to be more complex . T lU"ee 
distin ct genes encode th e lamiJliJl 5 polypeptide and mutations have 
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Figurc 3 . Blistcr forl11ation within th c lamina lucida , and prcscncc of hcnlidcsmosonlcs and a n c horing filanlcnts in intact and scparated 
dun. Transmiss io n electron rni croscopy at low magni fi catio n (A) reveals bliste r formation (slnr) within the lamina lucida. T he lamina dcnsa is shown by thc 
("TO"'''. At higher magni ficat io n (13) in in tact skin, sevcral well-formed hClllideS IllOSOl11 es (orn''''s) and subjacen t anchoring fi lam cnts arc sccn. Inncr and Outer 
hemidesmosomal plaq ues arc presen t (C), in addition to slIb-basa l dense plates and lIumero us allchoring fi laments (mTCIII's) . In the roofofa blister (D), several 
hemidcsmoso il1es (nrrows) with brush- like anchoring il lal1lents are seen that extend into the subjacent blister cavity (sr nr). (131'11', 0.5 p.m.) 
been described in th e genes for the {33 and ')'2 chains (LAMB3 and 
LAMC2, respectivel y) [1 4-16]. T he cDN A structure for the puta-
tive laminin 5 ex chajn has been publi shed [39], and mu tations in th e 
LA M A3 gene have also rece ntly been detected .§'l T he present cases 
involve LAMB3 mutations, including the first missense mutation 
within the {33 chain . Apart fr0111 1<1111inin 5, there is som e evidence 
to suggest that other candidate genes such as that encoding the 
lS0-kD bullous pemphigoid antigen (BPAG 2) m ay also be invo lved 
in the pa thogenesis of certa in form s of junctional EB [40]. Likewise, 
other ca ndidate genes including those for the basa l ce ll in tegrins, ex6 
and (34, might also be implicated 1"41] . 
§ Baudo in C, Abe rda111 D, C hristiano AM, Uitto J , O rtonne J - p, 
Meneguzzi G: Impaired expression of the LA MA3 genc causes Herli tz 
junctional ep idennolysis bullosa (abstr).) J" ""SI D",'/)/nro/ (in press) . 
'1 Kiv ilikko S, McGra th JA. C hri stiano AM. Baudoin C . D unnill MGS . 
C in tti S, McMillan JR., Aberdalll D, Eady K AJ. O rto l1nc J - P, MCl1cgll zzi G. 
UittoJ: A homozygous nonsensc mutation within the LA M A3 gene in le thal 
(HerIi tz) junctiona l epidennolysis bullDsa (abstr) .) J""esl Demlnro / (in press). 
In the o rigin al GAllEB family reported fro l11 A ust!;a l4], electron 
mi croscopy showed <1 rcdu ced nUl11ber of hemidesI11 osom es and 
associated anchoring fil<1m ents. However, varia bili ty in hel11jdes-
111 0S0111 e morpho logy has been documented in other GABEB 
paticn ts [7] . It is in te resticig to n ote, therefore , that the hem ides-
111 0somc-anchoring fi lam ent complexes in our patients wcre w e ll 
m aintained ul trastru cturall y, despite the considerable ovedap in the 
clinical appearances cif aU the reported GABEB patients. Of further 
in te rest is the observation that, in th e Austrian f..ITti ly, GB3 
antibody labeljng of the dermal-epidennal junction showed nonnal 
in tensi ty staining ** in con trast to the pa tients in our study. Fur-
thermore, labeling with a lSO-kD bullo us pemphigoid antigen 
** Pollia-Gubo G, Lazarova Z, Giudice G. Gr:l ssegger A, H intner H. 
Yancey K: T he nicein/epi ligrin/ ka linin (NEK) complex and related adhe-
sion molecules arc presen t in the epidermal basem ent m embrane of patients 
with generali zed atrophic benign junctional epiderm olysis bul\osa (GAB-
J E I3) (abstr) . ) J"",'sl Demlnl,,/ 102:562 . 1994. 
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Figure 4. Pre-embedding immunogold electron microscopy (i-nm gold witb silver enh ancement) using the GB3 (anti-laminin 
5) monoclonal antibody on nnfixed skin. In normal control skin (A), extensive labeling is present w ithin the lower lamina lucida , particularly 
beneath hemidcsmosomes. At higher magnificatio n (13), thi s labeling is associated with anch oriJlg fi lamcnts just above the lamina dcnsa. In intact paticnt 
skin (C), similar labe ling is present, altho ugh the labeling is reduced and patchy (compare arrowed sites). In blistc red paticnt skin (D), the im-
munogold labeling (anmvs) is present within the bli stcr base with no associa ted ancho ring fi laments. T he blister is depictcd by the asler;sk. In som e areas in 
patient skin (b) , foca l imm unogold aggregates o f anti-Iam inin 5 labe ling arc present with no adjacent normal pattern of lower lamina lucida labeling. (Bar, 
0.5 ILm.) 
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Figure 5. A nonsense mutation within LAMB3 exolt 3. H etcrodupl ex analysis (A ) shows band shifts in the three affected ind ividuals and in the materna l 
DNA. Nucleotide sequencing (B) revea ls a C-to-T subslitution (aml"'s) that changes an arg injnc rcsiduc (CGA) in to a premature termination codon (TGA) . 
Verification of th.e mutation (C) with D de I restriction cndonuclease digcstio n of the PCR prod ucts spanning cxon 3 rcs ults in two di stinct bands (246 and 
227 bp) in the mothcr's and three affected individuals' samples, and a single 246-bp band in th e othe r unafl:ccted fam il y mcmbers . Smaller digestion products 
of 11 0 and 69 bp arc detected in each ind ividua l. 
VOL. 104, NO. 4 APlUL 1995 
Or--------.--------~~ 
• 2J .. 
CAl 
eel 
(B). 
EX ON 
7 
INTRON 
7 
GATe 
NORMAL 
ALLELE 
LAMININ 5 IN JUNCTIONAL EB 473 
GATe 
MUTATED 
ALLELE 
628G-to-A 
A 
G 
Lys 
lIe 
Gin 
Gin / 
Lys 
Figure 6_ A missense mutation within LAMB3 exoll 7. H eteroduplex analysis (A ) shows bandshifts in the three nfl-ccted individuals DNA and also in 
the DNA fro m the father and two unaffected siblings. Nucleotide sequencing (B) revea]s a G-to-A substitution (nm)f l's) in the last nucleo tide of exon 7. This 
is the first nucleotide ofa spli t codon for a glu tamic acid residue (GAG) that is substituted by lysine (AAG) in the mutated alle le (fl/Hl"'S). Verification of the 
mutation (C) by ASO with a wild-type probe (top 1'011') and a mutated allcle probe (bOffO'" mill) that spall the mutation . Only the mother and one unaffected 
sibling arc homozygous for the wild-type allele. T he remaining fam ily members, including the three siblings with GABEB, are heterozygous for the 
nucleotide substitution . 
CONTROL PATIENT 
LAMB3 
GAPDH 
Figure 7. Reduced nlltNA levels ill an affected individual. Northern 
blotti ng shows that the LAMB3 signal ill the patien t is reduced to 
approximately 35% of that of the contro l signal intensity. Similar GAPD H 
labeling is present in both lanes signi fy ing equivaknt RNA loading. 
antibody showed reduced stamU1g in the Austrian patients,tt 
w hereas labelin g was of normal in tensity in o ur patients (data not 
shown) . T hese observations suggest that abnorm alities in several 
different adhesion molecules at the dermal-epidermal junction may 
give rise to JEB phenotypes, includin g those with cl inical features of 
GABEB . 
Analysis of the mutations so far reported in EB reveals th at many 
of the severe forms of the disorder, both junctional and dystrophic, 
involve the creatio n of a premature termination codon (PTC). Such 
mutations m ay lead to truncated polypeptides, and the PTC found 
near the 5' end of the mutated m<l terna l allcle (exon 3) in the 
present case would be expected to result in a severely truncated, 
no n-functiona l protein. However, apart fi'om m ere ly trunc<lting the 
peptide, it would appear that the main effect of this type of mutation 
is to create an unstable mRNA transcrip t [42 ,43 ]. T he N orthel'l1 
analysis presented here is consistent w ith such a hypothesis. 
'1''1 Pohla-Gubo G , Lazarova Z , Giudice G, Liebert M, Grassegger A, 
Hintner H, Yancey K: D im inished expression of the extracelluJar domain of 
bullous pemphigoid an tigel1 2 (BPAG2) il1 the ep idermal basemel1t mem-
brane (BM) of patients w ith genera lized atrophic benign junctional ep ider-
molysis bullos" (GABJEB) (abstr). e li" RI'S 42 :4 54A, 1994. 
The misse n.se mutation within ex on 7 appears to be of pathoge-
netic importance for several reasons. Firstly, it causes a significant 
polarity ch ilnge £i'om a negatively charged glutamic acid to a 
positively charged lysine residue. Secondly, the mutation occurs 
within part of laminin 5 that may be criticaJ for structmal interac-
tio ns with other basement membrane zon e macromolecules. 
T hirdly, th e ('nutation could not be demonstrated in 150 unrelated 
chromosomes within an edmically matched control population. 
T his mutation occurred within the last base pair of exol1 7 and 
might therefore also have an effect 011 RNA splicing. Exon 7 
con tain s 64 base pairs and consequently skipping of this exon would 
be out of fralTle leading to a PTC 22 base pairs downstream from 
the mutation (TGA, at nucleotide position 650-652). Taken in 
conjunction with the matemal mutated PTC allele, if such exon 
skipping would have occurred, the affected family members might 
be expected to have little, if any, stable LAMB3 transcript, no 
fun ctional protein, and almost inevitably a more severe, potentially 
lethal , phenotype. However, the re was no evidence of any abnor-
m al sp licing of exon 7 on RT-PCR assessment and the missense 
mutation was detected within the cDN A by ASO . 
T he exoJ'l 7 missense mutation occurs within domain VI of the 
molecule. In classical laminin (iaminin 1). the globular amino-
terminal don:lain VI within the {31 chain appears to have an 
important role in the self-assemb ly of laminin molecules ill "ilm 
[44,45]. In la minin 5, the corresponding domain VI, after post-
translational processing, is present only within the {33 chain, 
w hereas the 0'3 and ')'2 chains are truncated in comparison w ith the 
al and ')'1 c h a ins in laminin 1. T hu s, domain VI of the {33 chain may 
be important in the associatio n of l<lm in in 5 with other laminin 
m o lecules within the extracellular matrix. Assessment of the amino 
.1cid sequence of this part of the {33 chain gen e (LAMB3) reveals 
some functional differences with other laminin (3 ch ains, includ.ing 
an odd nUll1b er of cysteine residues [31]. It is possible that this part 
of the molecule interacts w ith the short arm of the laminin 6 
(K-Iaminin) a chain [46] and, in this way, contributes to the 
structural iJltegrity of the dermal-epidemlaJ junction. Such an 
association may be disrupted by the missense mutation within the 
mutated paternal allele in this particular fami ly . T he immunogold 
electro n mjc l'oscoPY findings of foca l anti-GB3 aggregates within 
the l<lmina lu cida could also be consisten t with laminin 5 {33 ch ains 
con ta ining t h e mutation being secreted in to the extracellular space 
bu t then being un able to associate with other base m ent m embrane 
zone ma cronlolecules . 
--- - ~---~--~~~-------~~ 
474 McGRATH ET AL 
In summary, this study has demonstrated the presence of both 
nonsense and missense mutations within the LAMB3 gene in three 
siblings with a non-lethal form of junctional epidermolysis bullosa. 
The results are of value in elucidating the pathogenetic mechanisms 
of this inherited skin disorder, and also in attempting to understand 
the complexities of adhesion between the epidermis and the 
underlying dermis. 
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